JPS60100557A - Preparation of guanidine derivative - Google Patents

Preparation of guanidine derivative

Info

Publication number
JPS60100557A
JPS60100557A JP58207200A JP20720083A JPS60100557A JP S60100557 A JPS60100557 A JP S60100557A JP 58207200 A JP58207200 A JP 58207200A JP 20720083 A JP20720083 A JP 20720083A JP S60100557 A JPS60100557 A JP S60100557A
Authority
JP
Japan
Prior art keywords
compound
reaction
methyl
cyano
alkali metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58207200A
Other languages
Japanese (ja)
Inventor
Dotaro Fujimoto
藤本 導太郎
Giichi Funatsukuri
船造 義一
Takeshi Sakai
酒井 武司
Shuhei Takamatsu
高松 修平
Masatoshi Sakae
栄 雅俊
Masanori Katsurada
正徳 桂田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujimoto Pharmaceutical Corp
Original Assignee
Fujimoto Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Pharmaceutical Corp filed Critical Fujimoto Pharmaceutical Corp
Priority to JP58207200A priority Critical patent/JPS60100557A/en
Publication of JPS60100557A publication Critical patent/JPS60100557A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

PURPOSE:To obtain cimetidine, by condensing 4-methyl-5-chloromethylimidazole with N-cyano-N', S-ethyleneisothiourea in the presence of a base, reacting the condensation product with methylamine, making the reaction product into an alkali metal salt, heating the salt. CONSTITUTION:4-Methyl-5-chloromethylimidazole or its hydrochloride is reacted with N-cyano-N', S-ethyleneisothiourea in the presence of a base to give a compound shown by the formula III, this compound is reacted with methylamine to give a compound shown by the formula IV, which is made into an alkali metal salt and heated at about 80-150 deg.C to give a guanidine derivative, especially N-cyano-N'-methyl-N'' [(4-methyl-5-imidazolymethylthio)ethyl]guanidine(namely, cimetidine). USE:A remedy for gastric ulcer and duodenal ulcer, having H2-acceptor antagonism.

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はグアニジン誘導体、特に式叩で示されるN−シ
アノ−N−メチル−N−1:(,4−メチル−5−イミ
ダゾリルメチルチオ)エチル〕グアニジンの製造法に関
する。 上記化合物(Vl、:Iは、H2−受容体拮抗作用を有
し、胃および十二脂賜潰瘍治療薬として有用な化合物で
、一般名をシメチジン(cimetidine)として
知られている。 従来、シメチジン〔■)の合成法として種々の方法が提
案されているが、それらは反応試薬としてシステアミン
(NH2CH2CH2SH)−このものは高価で、しか
も安定性に問題がある−を必要とし、また反応生成物を
精製するには再結晶を多数回繰返さねばならない。など
工業的に不向きな点が多い。その他に4−メチル−5−
メルカプトメチルイミダゾールのナトリウム塩とN−シ
アノ−N −メチル−N−(2−ブロモメチル)グアニ
ジンと反応させる合成法も知られているが、出発物質で
あるイミダゾール化合物がアルカリ条件下で酸化し易い
ため、生成物の収率は極めて低いのが難点である。本発
明はこれらの問題を解決したものである。 本発明方法は、 で示される4−メチル−5−クロロメチルイミダゾール
またはその塩酸塩と、 −CN で示されるN−シアノ−N’、S−エチレンイソチオウ
レアを塩基の存在下に反応させて で示されるN−シアノ−N、S−エチレン−N−((4
−メチル−5−イミダゾリル)メチル)インチオウレア
を得、この化合物とメチルアミンCIV)CHaNH2
(ff) とを反応させて、 メルカプトエチル)−N−((4−メチル−5−イミダ
ゾリル)メチル)グアニジンを得、ついでこの化合物の
アルカリ金属塩を加熱することを特徴とする。 化合物(1)と化合物〔11〕との縮合反応における塩
基性物質としては、金属ナトリウム、金属カリウム、金
属リチウム、水素化ナトリウム、水素化カリウム、水素
化リチウム、水酸化ナトリウム、水酸化カリウム、水酸
化リチウム、炭酸ナトリウム、炭酸カリウム、ナトリウ
ムアルコラード、カリウムアルコラードなどが好ましく
使用される。 また、グアニジンのような有機塩基を使用することもで
きる。 溶媒は、例えばメタノール、エタノールなどのアルコー
ル類、アセトン、アセトニトリル、ジメチルホルムアミ
ド、ジメチルスルホキシド、ピリジンなど”である。 上記反応は0℃から還流温度まで広い範囲で行うことが
でき、1〜2時間で反応の完結をみる。 なお、化合物〔l〕が塩酸塩である場合には、化合物〔
■〕は2倍モル量使用することが望ましい。過剰の化合
物〔ll)は反応後、反応生成物(化合物(Ill) 
)の分11i!操作の過程で回収し、再使用することが
できる。 化合物(III)とメチルアミン〔ハ〕との反応には、
溶媒として、メタノール、エタノールなどのアルコール
類、アセトン、アセトニトリル、ジメチルホルムアミド
、ジメチルスルホキシド等が使用されるが、メチルアミ
ン原液を溶媒として使用すると反応の円滑な進行をみる
。反応は室温において1〜2時間で完結し、反応後は溶
媒を留去するだけで化合物〔V〕が得られる。 上記反応により得られた化合物〔V〕を、アルカリ金属
塩(ナトリウム塩、カリウム塩、リチウム塩など)の形
で加熱することにより目的化合物〔■〕が得られる。 この反応は、化合物〔Y〕を溶媒中、アルカリ金属、ア
ルカリ金属水酸化物、アルカリ金属アルコキシドまたは
アルカリ金属水素化物で処理することにより達成される
。化合物〔v〕はアルカリ金属塩となり、ついで化合物
(Vl)に交換する。アルカリ金属は、例えばナトリウ
ム、カリウム、リチウムである。溶媒としては、メタノ
ール、エタノール、t−ブタノールなどのアルコール類
、ジメチルホルムアミド、ピリジンなどの極性溶媒が好
ましい。反応温度は80〜150℃の広範囲であり、2
〜5時間で反応の完結をみる。なお、この反応工程で生
成する目的化合物(1)は仙い塩基性条件下では一部分
解するが、逐次酸性物質を加えることにより収率の低下
を防ぐことができる。酸性物質としては、塩酸、硫酸、
酢酸、リン酸など、またはこれらの弱1fi Mとによ
る塩を使用ずれはよい。 実施例1 (A) 化合物0il)の製造: メタノール30m1に化合物(11〕2.54y(20
ミリモル)および水酸化ナトリウム0.80y(20ミ
リモル)を加える。15分tL拌したのち、化合物CI
)の塩酸塩1.67y(10ミリモル)を加え、1時間
撹拌する。溶媒を留去したのち、lN塩酸20mCを加
えて冷却すると過剰の化合物
The present invention relates to a method for producing guanidine derivatives, particularly N-cyano-N-methyl-N-1:(,4-methyl-5-imidazolylmethylthio)ethyl]guanidine. The above compound (Vl,:I) has H2-receptor antagonistic activity and is a compound useful as a therapeutic agent for gastric and deuteran ulcers, and its generic name is known as cimetidine. Conventionally, cimetidine Various methods have been proposed for the synthesis of [■), but they require cysteamine (NH2CH2CH2SH) as a reaction reagent, which is expensive and has stability problems, and they also require the production of reaction products. To purify it, recrystallization must be repeated many times. There are many points that make it unsuitable for industrial use. In addition, 4-methyl-5-
A synthetic method in which the sodium salt of mercaptomethylimidazole is reacted with N-cyano-N-methyl-N-(2-bromomethyl)guanidine is also known, but since the starting material, the imidazole compound, is easily oxidized under alkaline conditions. However, the problem is that the yield of the product is extremely low. The present invention solves these problems. The method of the present invention comprises reacting 4-methyl-5-chloromethylimidazole or its hydrochloride represented by the following with N-cyano-N',S-ethyleneisothiourea represented by -CN in the presence of a base. The indicated N-cyano-N, S-ethylene-N-((4
-Methyl-5-imidazolyl) methyl) inthiourea, and this compound and methylamine CIV) CHaNH2
(ff) to obtain mercaptoethyl)-N-((4-methyl-5-imidazolyl)methyl)guanidine, and then heat the alkali metal salt of this compound. Basic substances in the condensation reaction between compound (1) and compound [11] include sodium metal, potassium metal, lithium metal, sodium hydride, potassium hydride, lithium hydride, sodium hydroxide, potassium hydroxide, and water. Lithium oxide, sodium carbonate, potassium carbonate, sodium alcoholade, potassium alcoholade, and the like are preferably used. It is also possible to use organic bases such as guanidine. Examples of the solvent include alcohols such as methanol and ethanol, acetone, acetonitrile, dimethylformamide, dimethyl sulfoxide, and pyridine. Check for completion of the reaction. In addition, when compound [l] is a hydrochloride, compound [l]
(2) is preferably used in twice the molar amount. After the reaction, the excess compound [ll] is converted into a reaction product (compound (Ill)
) minute 11i! It can be recovered and reused during the process of operation. For the reaction between compound (III) and methylamine [c],
Alcohols such as methanol and ethanol, acetone, acetonitrile, dimethylformamide, dimethyl sulfoxide, etc. are used as the solvent, but the reaction proceeds smoothly when methylamine stock solution is used as the solvent. The reaction is completed in 1 to 2 hours at room temperature, and after the reaction, compound [V] can be obtained by simply distilling off the solvent. The target compound [■] is obtained by heating the compound [V] obtained by the above reaction in the form of an alkali metal salt (sodium salt, potassium salt, lithium salt, etc.). This reaction is achieved by treating compound [Y] with an alkali metal, alkali metal hydroxide, alkali metal alkoxide, or alkali metal hydride in a solvent. Compound [v] becomes an alkali metal salt and is then exchanged into compound (Vl). Alkali metals are, for example, sodium, potassium, lithium. As the solvent, alcohols such as methanol, ethanol, and t-butanol, and polar solvents such as dimethylformamide and pyridine are preferable. The reaction temperature ranged from 80 to 150°C, and
The reaction was completed in ~5 hours. Note that although the target compound (1) produced in this reaction step is partially decomposed under slightly basic conditions, a decrease in yield can be prevented by sequentially adding an acidic substance. Acidic substances include hydrochloric acid, sulfuric acid,
It is better to use acetic acid, phosphoric acid, etc., or their weak 1fiM salts. Example 1 (A) Production of compound (0il): Add 2.54y (20ml) of compound (11) to 30ml of methanol.
mmol) and 0.80y (20 mmol) of sodium hydroxide. After stirring for 15 min, compound CI
) and stirred for 1 hour. After distilling off the solvent, add 1N hydrochloric acid (20 mC) and cool to remove excess compound.

〔0〕が析出するので、こ
れをp取し回収する(回収率84.7%)。n3Mを炭
酸カリウムでアルカリ性にすると結晶が析出する。これ
をP取し、エタノールから再結晶して化合物[111)
 1.357 j/を得る。収率61.4%。 融点183〜184℃ 元素分析値(C9HtIN5 Sとして)計算値(%)
:C48,85、H5,01、N31.65、実測値(
チ):C48,61、H5,02、N31.62゜−I
R(Nu jo 1 ) 二’l 2 0 0 t l
 b 9 0 cm 。 NMR(DMSO−d、):δ2.20 (S+ CH
8+3H)、δ3,20〜3.60てt、NCH2CH
25゜2H)、δ8.76〜4゜l O(t、 NCH
2,CH25128)、δ4.43(S、ベザ2N 2
H)、δ7.46IH)。1( (B) 化合物〔v〕の製造: メチルアミンlodを冷却し、これに化合物〔出)1.
106y(5ミリモル)を加え、封管して室温で70分
間撹拌する。反応終了後、メチルアミンを留去して化合
物(Y)を得る。得られた化合物CDはそのまま次の合
成工程に用いることができる。単離する場合には次のよ
うに2.4−ジニトロクロルベンゼン誘導体として単彫
される。例えば、化合物CDをエタノール15−に溶解
し、これに水酸化ナトリウム0.2yを水1.5 me
に溶解した液を加えたのち、2.4−ジニトロクロルベ
ンゼン1.olyをエタノール25meに溶解した液に
注入する。このとき、化合物CDは足糸的に反応してス
ルフィドを沈澱する。水蒸負謬上で10分間加熱して浴
解しすばやく濾過して冷却すると黄色針状結晶が析出す
る。これをエーテル、水で況浄し乾燥する。収量1.9
02p(91,0チ)。融点206〜207℃。 (C)シメチジン〔v1〕の裂Qニ ジメチルホルムアミド(IJMF)20mEに上記で得
られた化合物〔v〕を溶解し、冷却下に水系化ナトリウ
ム(NaH)0.24?(5ミリモル)を加え、10分
間撹拌する。反応M液を30分を要して85℃に加熱し
、窒素気流中、そのU度で2時18145分保持して反
応を完結させる。反応途中、温度85℃匂達15分後か
ら反応終了まで、61:酸0、57 meを含むDMF
溶液10 meを0.31nlずつ15分間隔で添加す
る。反応終了後、溶媒、を留去し、5N水酸化ナトリウ
ム2511If!を加え、酢酸エチル30dで3回抽出
する。酢酸エチル層を硫酸ナトリウムで乾燥したのち濃
縮し、ワコーゲルC−300109を用い、酢飯エチル
を溶媒としてカラムクロマトグラフィーに付す。目的分
画を集めたのち、溶妹を留去し、アセトニトリル力)ら
結晶化させてシメチジンC%1) 0.8979を得る
。 収率71.2チ(化合物CDから)。 融点140〜141℃ 元素分析(CIOHta Na S として)計算値(
チ):C47,60,H6,39、N38.30、実測
値(幻:C47,59、)[6,37、N3B、29゜
実施例2 (A) 化合物Cm)の製造: DMF20meを冷却し、50チ水素化ナトリウム0.
48p(10ミリモル)を加えたのち、化合物(11)
1.27y(10ミリモル)を除々番と加える。 水素の発生が止むまで撹拌したのち、化合物CI)の塩
酸塩0.835y(5ミ!Jモル)を除々に加え2時間
撹拌する。反応終了後、溶媒を留去し、IN塩酸を加え
て冷却する。析出した過剰の化合物〔l)を戸数し回収
する(回収率76.2%)。υ” 71kを酢酸エチル
で洗浄したのち、P液を炭亀カリウムでアルカリ性にし
て結晶を析出させる。結晶を1戸取し、エタノールから
再結in″・して化合物〔IJ1〕o、895&を得る
。収率81.0≠。/+ijt点183〜1 84 ℃ (B) 化合物〔v〕の製造: 実施例1〔B〕と同様にして化合物CDをイ6゛る。 (C) 化合物DI)の製造: DMF20meに上B+j −((J タ化合’rA 
(1”J ’2加え、水酸化ナトリウム0.2y(5ミ
リモル)を添加し、15分間撹拌する。反応温度を80
°Cとし、窒素気流中5時間で反応の完結をみる。反応
終了後、溶媒を留去し、5N水酸化ナトリウム水溶液2
゜dを加え、酊叡エチル15meで4回抽出する。酢酸
エチル層を乾燥し、乾固したのら、少量の溶離液(タロ
ロポルム:メタノール−9:1)に溶解し、ワコーゲル
C−300を用いてカラムクロマトクラフィーに付す。 目的分画を集め溶媒を留去し、アセトニトリルから結晶
化させてシメチジン000、782 pを得る。収率6
2,1%(化合物〔v〕から)。融点140〜l 41
’e。 実施例3 (A) 化合物(ill)の製造: 水酸化ナトリウム0.8(1/(20ミリモル)を加熱
俗解したピリジン50meに化合物〔LD 2.54y
(20ミリモル)を加え、10分間撹拌したのち、化合
物〔■〕の塩酸塩1.67@(10ミリモル)を加え、
90分間撹拌する。溶媒を留去し、IN塩酸2− Om
eを加えて冷却すると過剰の化合物CIDが析出するの
で、これをi月収し回収する(回収率77.51.、炉
液を炭酸カリウムでアルカリ性に調h11すると結晶が
析出する。これをp取しエタノールから再結晶して化合
43 C11j) 1.7069を街る。 収率77.2%。 (B) 化合物〔v〕の製造: 実施例1〔B〕と同様にして化合物CDを得る。 (C) 化合物00の製造: ピリジン20meに上記化合物〔v〕を溶解し、これに
水酸化ナトリウム0.2(J5’(5ミリモル)を加え
10分間撹拌する。反応溶液を85℃に加熱し、窒素気
流中、2時IFD 45分反応させる。途中、85°C
到達40〜60分後から反応終了まで、酢酸0.57 
meを含むピリジンン容液lameを5〜1.0me/
 Hrの速度で添加する。反応終了後、実施例2〔C〕
と同様に処理してシメチジン〔〜l〕0.7222を得
る。収率57.3%(化合物〔v〕から)。融点140
〜141’C0 実施例4 (A) 化合物(ill)の製造: D M F 40 meに水酸化リチウム1水塩0.8
4y(20ミリモル)を加熱溶解し、これに化合物C1
1’32.54 fl (20ミリモル)を加え10分
間撹拌したのち、化合物〔1〕の塩酸塩1.671(1
0ミリモル)を添加し、1時間撹拌する。反応終了後、
溶媒を留去し、INtliii酸を加えて冷却すると過
剰の化合物〔■〕が析出するのでこれを戸取し回収する
(回収率67.5 % )。rPn’t、を水酸化ナト
リウムでアルカリ性に調節すると結晶が析出1−る。 結晶をF取し、エタノールから再結晶して化合物(II
I〕1.83 yを得る。収率83チ。 (B) 化合物CDの製造: 実施例I CE)と同様にして化合物〔v〕を得る。 (C) 化合物〔■〕の製造: DMF40meに上記の化合物〔v〕を溶解し、これに
水酸化リチウム1水tfa0.21p(5ミlJモル)
を加え、15分間撹拌する。反応溶液を100℃に加熱
し、窒素気流中で2時間反応させる。反応終了後、溶媒
を留去し、実施例2〔c〕と同様にその後の処理を行い
シメチジン(Vl) 0.689 Yを得る。収率54
.7%(化合物〔v〕から)。融点140〜141 ℃
。 上記各実施例で得られた化合物〔vI〕の融点および赤
外吸収スペクトルは標品のシメチジンのそれと一致する
。 代理人 弁理士 宮崎新八部
Since [0] is precipitated, it is collected as P (recovery rate 84.7%). When n3M is made alkaline with potassium carbonate, crystals precipitate. P was removed from this and recrystallized from ethanol to form compound [111]
We get 1.357 j/. Yield 61.4%. Melting point 183-184℃ Elemental analysis value (as C9HtIN5S) Calculated value (%)
:C48.85, H5.01, N31.65, actual value (
H): C48,61, H5,02, N31.62°-I
R(Nu jo 1) 2'l 2 0 0 t l
b 90 cm. NMR (DMSO-d,): δ2.20 (S+ CH
8+3H), δ3, 20-3.60t, NCH2CH
25゜2H), δ8.76~4゜l O(t, NCH
2, CH25128), δ4.43 (S, Beza 2N 2
H), δ7.46IH). 1 ((B) Production of compound [v]: Cool the methylamine lod, and add compound [v] to it.
Add 106y (5 mmol), seal the tube, and stir at room temperature for 70 minutes. After the reaction is completed, methylamine is distilled off to obtain compound (Y). The obtained compound CD can be used as it is in the next synthesis step. When isolated, it is isolated as a 2,4-dinitrochlorobenzene derivative as follows. For example, compound CD is dissolved in 15-ml of ethanol, and 0.2y of sodium hydroxide is added to 1.5ml of water.
After adding the solution dissolved in 2,4-dinitrochlorobenzene 1. Inject oly into a solution of ethanol 25me. At this time, compound CD reacts in a byssus manner to precipitate sulfide. The solution is heated on a steam oven for 10 minutes to dissolve the solution, quickly filtered, and cooled to precipitate yellow needle-like crystals. Clean this with ether and water and dry. Yield 1.9
02p (91,0chi). Melting point: 206-207°C. (C) Dissolve the compound [v] obtained above in 20 mE of cimetidine [v1] dimethylformamide (IJMF) and form an aqueous solution of 0.24% sodium (NaH) under cooling. (5 mmol) and stir for 10 minutes. The reaction M solution was heated to 85° C. over 30 minutes and maintained at that temperature in a nitrogen stream for 2:18,145 minutes to complete the reaction. During the reaction, from 15 minutes after reaching the temperature of 85°C until the end of the reaction, DMF containing 61: acid 0, 57 me
Add 0.31 nl of solution 10 me at 15 minute intervals. After the reaction, the solvent was distilled off and 5N sodium hydroxide 2511If! and extracted three times with 30 d of ethyl acetate. The ethyl acetate layer was dried over sodium sulfate, concentrated, and subjected to column chromatography using Wakogel C-300109 and ethyl vinegar as a solvent. After collecting the desired fractions, the dissolved fractions are distilled off and crystallized from acetonitrile to obtain cimetidine C%1) 0.8979. Yield 71.2cm (from compound CD). Melting point 140-141℃ Elemental analysis (as CIOHta Na S) Calculated value (
H): C47,60, H6,39, N38.30, actual value (phantom: C47,59,) [6,37, N3B, 29° Example 2 (A) Production of compound Cm): Cool DMF20me , 50 sodium hydride 0.
After adding 48p (10 mmol), compound (11)
Add 1.27y (10 mmol) gradually. After stirring until the evolution of hydrogen stops, 0.835y (5 mm!J mol) of the hydrochloride of compound CI) is gradually added and stirred for 2 hours. After the reaction is completed, the solvent is distilled off, IN hydrochloric acid is added, and the mixture is cooled. The precipitated excess compound [l] is collected in several cases (recovery rate 76.2%). After washing υ" 71k with ethyl acetate, the P solution is made alkaline with potassium carbonate to precipitate crystals. One crystal is taken and reconstituted with ethanol to form the compound [IJ1]o, 895&. obtain. Yield 81.0≠. /+ijt point 183-184°C (B) Production of compound [v]: Compound CD was prepared in the same manner as in Example 1 [B]. (C) Production of compound DI): B+j −((J ta compound'rA
Add 0.2y (5 mmol) of sodium hydroxide and stir for 15 minutes. Reduce the reaction temperature to 80
°C and complete the reaction in a nitrogen stream for 5 hours. After the reaction, the solvent was distilled off and 5N sodium hydroxide aqueous solution 2
Add ゜d and extract 4 times with ethyl 15me. After drying the ethyl acetate layer to dryness, it is dissolved in a small amount of eluent (taloloporum: methanol - 9:1) and subjected to column chromatography using Wakogel C-300. The desired fractions are collected, the solvent is distilled off, and the fractions are crystallized from acetonitrile to obtain cimetidine 000,782p. Yield 6
2.1% (from compound [v]). Melting point 140~l 41
'e. Example 3 (A) Production of compound (ill): Compound [LD 2.54y
(20 mmol) was added, and after stirring for 10 minutes, 1.67 @ (10 mmol) of hydrochloride of compound [■] was added.
Stir for 90 minutes. The solvent was distilled off and IN hydrochloric acid 2-Om
When e is added and cooled, excess compound CID is precipitated, so this is collected and collected every i month (recovery rate 77.51).When the furnace liquid is made alkaline with potassium carbonate h11, crystals are precipitated. The compound 43C11j) 1.7069 is obtained by recrystallization from ethanol. Yield 77.2%. (B) Production of compound [v]: Compound CD is obtained in the same manner as in Example 1 [B]. (C) Production of compound 00: Dissolve the above compound [v] in 20me of pyridine, add 0.2 (J5' (5 mmol) of sodium hydroxide) and stir for 10 minutes. Heat the reaction solution to 85 ° C. , in a nitrogen stream, 2:00 IFD for 45 minutes. During the reaction, 85°C.
From 40 to 60 minutes after arrival until the end of the reaction, acetic acid 0.57
Add pyridine solution lame containing 5 to 1.0 me/
Add at a rate of Hr. After completion of the reaction, Example 2 [C]
Cimetidine [~l]0.7222 was obtained by treatment in the same manner as above. Yield 57.3% (from compound [v]). Melting point 140
~141'C0 Example 4 (A) Production of compound (ill): 0.8 lithium hydroxide monohydrate in DMF40me
4y (20 mmol) was heated and dissolved, and compound C1 was added to it.
After adding 1'32.54 fl (20 mmol) and stirring for 10 minutes, 1.671 (1
0 mmol) and stirred for 1 hour. After the reaction is complete,
When the solvent is distilled off, INtliii acid is added and the mixture is cooled, an excess of the compound [■] is precipitated and collected at home (recovery rate: 67.5%). When rPn't is made alkaline with sodium hydroxide, crystals are precipitated. The crystals were collected from F and recrystallized from ethanol to obtain compound (II
I] Obtain 1.83 y. Yield: 83 cm. (B) Production of compound CD: Compound [v] is obtained in the same manner as in Example I CE). (C) Production of compound [■]: Dissolve the above compound [v] in DMF40me, add lithium hydroxide 1 water tfa0.21p (5 ml J mol)
and stir for 15 minutes. The reaction solution is heated to 100° C. and reacted for 2 hours in a nitrogen stream. After the reaction is completed, the solvent is distilled off, and the subsequent treatment is carried out in the same manner as in Example 2 [c] to obtain cimetidine (Vl) 0.689 Y. Yield 54
.. 7% (from compound [v]). Melting point 140-141℃
. The melting point and infrared absorption spectrum of the compound [vI] obtained in each of the above Examples match those of the standard cimetidine. Agent Patent Attorney Miyazaki Shinhachibe

Claims (1)

【特許請求の範囲】[Claims] (1)4−メチル−5−クロロメチルイミダゾールもし
くはその塩酸塩と、N−シアノ−N、S−エチレンイソ
チオウレアを塩基の存在下に反応さて示される化合物を
得、この化合物とメチルアミで示される化合物を得、つ
いでそのアルカリ金属塩を加熱することを特徴とする、 で示されるグアニジン誘導体の製造法。
(1) 4-Methyl-5-chloromethylimidazole or its hydrochloride and N-cyano-N,S-ethyleneisothiourea are reacted in the presence of a base to obtain the compound shown, and this compound and methylamine A method for producing a guanidine derivative represented by the following, characterized in that the compound is obtained and then the alkali metal salt thereof is heated.
JP58207200A 1983-11-04 1983-11-04 Preparation of guanidine derivative Pending JPS60100557A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58207200A JPS60100557A (en) 1983-11-04 1983-11-04 Preparation of guanidine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58207200A JPS60100557A (en) 1983-11-04 1983-11-04 Preparation of guanidine derivative

Publications (1)

Publication Number Publication Date
JPS60100557A true JPS60100557A (en) 1985-06-04

Family

ID=16535895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58207200A Pending JPS60100557A (en) 1983-11-04 1983-11-04 Preparation of guanidine derivative

Country Status (1)

Country Link
JP (1) JPS60100557A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235725A2 (en) * 1986-03-07 1987-09-09 Nihon Bayer Agrochem K.K. Heterocyclic compounds
JPS63203672A (en) * 1987-02-20 1988-08-23 Kowa Co Novel heterocyclic compound
CN114394939A (en) * 2022-01-27 2022-04-26 河北科技大学 Synthesis method of cimetidine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235725A2 (en) * 1986-03-07 1987-09-09 Nihon Bayer Agrochem K.K. Heterocyclic compounds
JPS62207266A (en) * 1986-03-07 1987-09-11 Nippon Tokushu Noyaku Seizo Kk Novel heterocyclic compound
JPS63203672A (en) * 1987-02-20 1988-08-23 Kowa Co Novel heterocyclic compound
JP2607369B2 (en) * 1987-02-20 1997-05-07 興和株式会社 New heterocyclic compounds
CN114394939A (en) * 2022-01-27 2022-04-26 河北科技大学 Synthesis method of cimetidine

Similar Documents

Publication Publication Date Title
EP0274379B1 (en) Process for preparing pyridine-2,3-dicarboxylic acid compounds
JP3850838B2 (en) Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
US5101067A (en) 2-amino-3-halomaleic acid esters
JPS60100557A (en) Preparation of guanidine derivative
Kuritani et al. Optically Active Triptycenes, V. Synthesis, Optical Resolution and Absolute Configuration of 2, 7-Disubstituted Triptycenes.
JPS62161766A (en) Imidazole n-oxide compound and manufacture
JP2020528437A (en) A novel intermediate useful for the synthesis of aminopyrimidine derivatives, the process for preparing it, and the process for preparing aminopyrimidine derivatives using it.
JPS62192382A (en) Production of mercaptopyrazolopyrimidine
US4560764A (en) Synthesis of an imidazolyl isothiourea
JPH0641135A (en) Imidazopteridine derivative and its production
JP3161690B2 (en) Method for producing 2-mercaptoimidazole fused ring compound
US4468518A (en) Imidazole guanidine compounds and method of making same
JPS5916878A (en) Production of 2,4-dihydroxy-3-acetylquinoline
JPS6160673A (en) Preparation of guanidinothiazole derivative
US4520201A (en) Synthesis of cimetidine and analogs thereof
JP2561500B2 (en) Process for producing pyridine-2,3-dicarboxylic acid derivative
JPS6021590B2 (en) Method for producing 2-amino- and 2-(disubstituted amino)-4,5-diarylimidazoles
JPH0379345B2 (en)
JPS6388169A (en) Novel 5-alkylsulfonyl- and 5-alkenylsulfonyl- 2,4,6-trihalopyrimidine and manufacture
JPH0616640A (en) Production of 2-mercaptopyridines
JP3886751B2 (en) Method for producing guanidine derivative
RU2158730C1 (en) Acrylic acid o-bromoanilide and utilization thereof in preparation of beta-diethylaminopropionic acid o-bromoanilide hydrochloride
JPS59216882A (en) Production of 2,4-oxazolidinedione derivative
JPS5811951B2 (en) Method for producing 2-benzothiazolinone derivative
JPS63216861A (en) Production of 4-hydroxyindolines